• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

    21.94 +0.62 (+2.91%)
    Streaming Delayed Price Updated: 3:41 PM EDT, Aug 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 441,303
    Open 21.69
    Bid (Size) 21.93 (200)
    Ask (Size) 21.95 (500)
    Prev. Close 21.32
    Today's Range 21.59 - 22.20
    52wk Range 16.66 - 42.43
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Kaplan Fox Advises PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Act Before the Lead Plaintiff Deadline on September 22, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    Attention Long-Term Shareholders of AeroVironment, Inc. (NASDAQ: AVAV); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); Roblox Corporation (NYSE: RBLX) and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your
    From Grabar Law Office
    Via GlobeNewswire

    Performance

    YTD
    -28.7%
    -28.7%
    1 Month
    +14.2%
    +14.2%
    3 Month
    -15.3%
    -15.3%
    6 Month
    -22.0%
    -22.0%
    1 Year
    -46.1%
    -46.1%

    More News

    Read More
    News headline image
    PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire
    News headline image
    Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Deadline on September 22, 2026
    Via NewMediaWire
    Topics Lawsuit Retirement
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026
    Via NewMediaWire
    Topics Lawsuit Retirement
    News headline image
    PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Attention Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); Primoris Services Corporation (NYSE: PRIM); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and Roblox Corporation (NYSE: RBLX): Grabar Law Office is Investigating
    From Grabar Law Office
    Via GlobeNewswire
    News headline image
    Robbins LLP Encourages PRCT Shareholders With Significant Losses to Contact the Firm for Information About the Class Action Against PROCEPT BioRobotics Corporation
    From Robbins LLP
    Via Business Wire
    News headline image
    Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights
    Via NewMediaWire
    Topics Lawsuit Retirement
    News headline image
    PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
    Via Newsfile
    Topics Fraud Lawsuit
    News headline image
    Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 22, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is September 22, 2026
    Via NewMediaWire
    Topics Fraud Lawsuit Retirement
    News headline image
    PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
    Via Newsfile
    Topics Fraud Lawsuit
    News headline image
    Kaplan Fox Advises PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Act Before the Lead Plaintiff Deadline on September 22, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 22, 2026 Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
    Via NewMediaWire
    Topics Lawsuit Retirement
    News headline image
    PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
    Via Newsfile
    Topics Fraud Lawsuit
    News headline image
    Kaplan Fox Continues to Alert Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Class Action Deadline on September 22, 2026
    Via NewMediaWire
    Topics Lawsuit Retirement
    News headline image
    PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026
    Via NewMediaWire
    Topics Lawsuit Retirement

    Frequently Asked Questions

    Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?
    Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
    What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
    PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
    The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
    What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
    The current price of PROCEPT BioRobotics Corporation - Common Stock is 21.94
    When was PROCEPT BioRobotics Corporation - Common Stock last traded?
    The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 08/19/26 03:41 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.